Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

An estimated 3.4 million Brits meet the criteria to receive a prescription for Wegovy and Mounjaro which would cost £10billion a year. All weight loss jabs, including Ozempic, contain semaglutide ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

Also, be sure to check out the drug manufacturer’s website for information about the Wegovy savings card. If you have questions about how to pay for your prescription, talk with your doctor or ...

More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Investing.com -- Bernstein analysts highlighted a more attractive valuation for Novo Nordisk (NYSE: NVO) following recent ...